and certain mildly activating mutations are the least deleterious.'6 Some naturally occurring mutations of the human thyrotrophin receptor are more strongly activating than others, including some that involve the phosphoinositide hydrolysis pathway.'7 Although no clear association has yet been made between allelic heterogeneity and the severity of thyroid hyperplasia or hyperfunction, somatic thyrotrophin receptor mutations tend to be more activating than those found in cases of hereditary toxic thyroid hyperplasia." 18 In regards to the LHR gene, the recent description of a testotoxicosis kindred in which one 12 year old prepubertal boy was found to have an activating M398T mutation indicates that not all mutant alleles exhibit 100% penetrance.
The age of presentation and degree of Leydig cell hyperplasia and raised serum testosterone in our patient clearly distinguishes him from the majority of familial and sporadic testotoxicosis cases that have been published.' 9 10 Furthermore, his mutant LHR exhibits a level of constitutive signalling that is much greater than that produced by the other mutant receptors associated with testotoxicosis.4 "1 Our findings confirm and extend those from two other young boys with non-familial testotoxicosis4 '7 8 and suggest that these unusually early and severe clinical presentations of testotoxicosis are directly related to the strongly activating nature of the de novo D578Y substitution. 
